Skip to main content
Log in

Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The purpose of the study was to establish a diagnostic approach to the preparation of patients with colorectal liver metastases considered for transarterial radioembolization (RE). Twenty-two patients sequentially underwent computed tomography (CT; thorax/abdomen), magnetic resonance imaging (MRI; liver; hepatocyte-specific contrast), positron emission tomography (PET/PET-CT; F18-fluoro-desoxy-glucose), and angiography with perfusion scintigraphy [planar imaging; tomography with integrated CT (SPECT-CT)]. The algorithm was continued when no contraindication or alternative treatment option was found. The impact of each test on the therapy decision and RE management was recorded. Patient evaluation using CT revealed contraindications for RE in 4/22 patients (18%). Of the remaining 18 patients, 2 were excluded and 3 were assigned to locally ablative treatment based on MRI and PET results (28%). The remaining 13 patients entered the planning algorithm: SPECT-CT revealed gastrointestinal tracer accumulations in 4 (31%) patients [SPECT, 2 (15%)], making a modified application necessary. In five patients (38%), planar scintigraphy revealed relevant hepatopulmonary shunting. Therapy was finally administered to all 13 patients without therapy-related pulmonary or gastrointestinal morbidity. Each part of the diagnostic algorithm showed a relevant impact on patient management. The sequential approach appears to be suitable and keeps the number of unnecessary treatments and therapy risks to a minimum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047

    Article  PubMed  CAS  Google Scholar 

  2. Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK, Hart LL, Gupta S, Garay CA, Burger BG, Le Bail N, Haller DG (2003) Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21:2059–2069

    Article  PubMed  CAS  Google Scholar 

  3. Kemeny N (2006) Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20:1161–1176

    Google Scholar 

  4. Khatri VP, Petrelli NJ, Belghiti J (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit. J Clin Oncol 23:8490–8499

    Article  PubMed  Google Scholar 

  5. Vibert E, Canedo L, Adam R (2005) Strategies to treat primary unresectable colorectal liver metastases. Semin Oncol 32(6Suppl8):33–39

    Article  PubMed  Google Scholar 

  6. Kopetz S, Hoff PM (2005) Cytotoxic chemotherapy for advanced colorectal cancer: Recent advances in management. Oncology (Williston Park) 19(13Suppl6):11–17

    Google Scholar 

  7. Berber E, Pelley R, Siperstein AE (2005) Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23:1358–1364

    Article  PubMed  Google Scholar 

  8. Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 18(Suppl2):ii25-ii26

  9. Nolsoe CP, Torp-Pedersen S, Burcharth F, Horn T, Pedersen S, Christensen NE, Olldag ES, Andersen PH, Karstrup S, Lorentzen T et al (1993) Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology 187:333–337

    PubMed  CAS  Google Scholar 

  10. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy–local tumor control rate and survival data. Radiology 230:450–458

    Article  PubMed  Google Scholar 

  11. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G, Spors B, Werk M, Rosner C, Hanninen EL, Felix R (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–1505

    Article  PubMed  Google Scholar 

  12. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, Pech M, Werk M, Rosner C, Hanninen EL, Freund T, Felix R (2004) Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 15:1279–1286

    PubMed  Google Scholar 

  13. Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258

    Article  PubMed  CAS  Google Scholar 

  14. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl1):S41–S55

    Article  PubMed  Google Scholar 

  15. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969–977

    PubMed  CAS  Google Scholar 

  16. Ariel IM (1965) Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 162:267–278

    Article  PubMed  CAS  Google Scholar 

  17. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, Gebski V (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720

    Article  PubMed  CAS  Google Scholar 

  18. Jakobs TF, Hoffmann RT, Poepperl G, Schmitz A, Lutz J, Koch W, Tatsch K, Lubiensky A, Reiser MF, Helmberger T (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17:1320–1330

    Article  PubMed  Google Scholar 

  19. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85

    Article  PubMed  CAS  Google Scholar 

  20. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE Jr, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425

    PubMed  CAS  Google Scholar 

  21. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35:1637–1644

    PubMed  CAS  Google Scholar 

  22. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Interv Radiol 30:571–592

    Article  Google Scholar 

  23. Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278

    Article  PubMed  Google Scholar 

  24. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23

    PubMed  Google Scholar 

  25. Amthauer H, Denecke T, Hildebrandt B, Ruhl R, Miersch A, Nicolaou A, Ruf J, Plotkin M, Hanninen EL, Stroszczynski C, Gutberlet M, Langrehr J, Riess H, Ricke J (2006) Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions. Nuklearmedizin 45:177–184

    PubMed  CAS  Google Scholar 

  26. Denecke T, Steffen I, Hildebrandt B, Ruhl R, Streitparth F, Lehmkuhl L, Langrehr J, Ricke J, Amthauer H, Hanninen EL (2007) Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: Contribution of FDG-PET in patients with clinical suspicion of progressive disease. Acta Radiol 48:821–830

    Article  PubMed  CAS  Google Scholar 

  27. Cosin O, Bilbao JI, Alvarez S, de Luis E, Alonso A, Martinez-Cuesta A (2007) Right gastric artery embolization prior to treatment with Yttrium-90 microspheres. Cardiovasc Intervent Radiol 30:98–103

    Article  PubMed  Google Scholar 

  28. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561

    Article  PubMed  Google Scholar 

  29. Carretero C, Munoz-Navas M, Betes M, Angos R, Subtil JC, Fernandez-Urien I, De la Riva S, Sola J, Bilbao JI, de Luis E, Sangro B (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102:1216–1220

    Article  PubMed  Google Scholar 

  30. Denecke T, Hildebrandt B, Lehmkuhl L, Peters N, Nicolaou A, Pech M, Riess H, Ricke J, Felix R, Amthauer H (2005) Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur J Nucl Med Mol Imaging 32:1003–1010

    Article  PubMed  CAS  Google Scholar 

  31. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney A (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345

    PubMed  Google Scholar 

  32. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41:1177–1189

    PubMed  CAS  Google Scholar 

  33. Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054

    Article  PubMed  CAS  Google Scholar 

  34. Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803

    PubMed  Google Scholar 

  35. Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H (2005) Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy. Rofo 177:1235–1241

    PubMed  CAS  Google Scholar 

  36. Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: A prospective study with intraoperative confirmation. Acta Radiol 48:369–378

    Article  PubMed  CAS  Google Scholar 

  37. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic Yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16(2Pt1):195–203

    PubMed  Google Scholar 

  38. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic Yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16(2Pt1):205–213

    PubMed  Google Scholar 

  39. Lehmkuhl L, Denecke T, Warschewske G, Hildebrandt B, Nicolaou A, Riess H, Hanninen EL, Felix R, Ricke J (2007) Multislice computed tomographic angiography for preinterventional planning of port placement for intra-arterial hepatic infusion chemotherapy. J Comput Assist Tomogr 31:66–71

    Article  PubMed  Google Scholar 

  40. Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Barrett K, Gowland P, Oman B, Lewandowski RJ, Gates VL, Thurston KG, Wong CY (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timm Denecke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denecke, T., Rühl, R., Hildebrandt, B. et al. Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 18, 892–902 (2008). https://doi.org/10.1007/s00330-007-0836-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-007-0836-2

Keywords

Navigation